Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore professional investment ideas sourced from institutional letters, short theses, and premium research channels, distilled into concise summaries.
| Pitch Type | Author | Industry | Pitch Thesis & Key Summary | Bull/Bear | Action | ||
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Fund Letter | Zeno Equity Partners LLPZeno | Danaher Corp. $DHR• NYSE | Life Sciences Tools & ServicesLife Sciences Tools & Services | Zeno - DHR In this letter, we will argue that our largest position, Danaher, is a precise manifestation of this archetype of business, clearly demonstrating market power and a rewarding reinvestment opportunity. We will also... | NEUTRAL | View Pitch → |
| Sep 2, 2026 | Fund Letter | Howard GleicherAristotle Value Equity Fund | Danaher Corp. $DHR• NYSE | Life Sciences Tools & ServicesLife Sciences Tools & Services | Aristotle Value Equity Fund - DHR We first invested in Danaher, a company focused on biotechnology, life sciences and diagnostics, in the second quarter of 2016, attracted by its disciplined capital allocation, differentiated operating culture and consistent FREE cash flow generation. The business is... | BULL | View Pitch → |
| Sep 2, 2026 | Fund Letter | Aristotle_Saul Global Equity Fund | Danaher Corp. $DHR• NYSE | Life Sciences Tools & ServicesLife Sciences Tools & Services | Aristotle Saul Global Equity Fund - DHR We first invested in Danaher, a company focused on biotechnology, life sciences and diagnostics, in the first quarter of 2016, attracted by its disciplined capital allocation, differentiated operating culture and consistent FREE cash flow generation. The business is... | BULL | View Pitch → |
| Aug 18, 2026 | Substack | borlaugSubstack (borlaug) | Danaher Corp. $DHR• NYSE | Life Sciences Tools & ServicesLife Sciences Tools & Services | #10: DanahurtDanaher Corporation – DHR Danaher Corporation faces challenges in its bioprocessing segment, with guidance indicating lower-than-expected growth. The company's reliance... | BEAR | View Pitch → |
| Feb 25, 2026 | Fund Letter | Dr. Hendrik LeberACATIS Investment | Danaher Corp. $DHR• NYSE | Life Sciences Tools & ServicesLife Sciences Tools & Services | ACATIS Investment 2025 Q4 (DHR) This stock, a specialist for life sciences and diagnostics, was sold because the high valuation does not offer a lot of upward potential at the moment, considering the moderate growth outlook and stagnating equipment sales. At this time,... | BEAR | View Pitch → |
| Feb 3, 2026 | Fund Letter | Alex UmanskyBaron Durable Advantage Fund | Danaher Corp. $DHR• NYSE | Life Sciences Tools & ServicesLife Sciences Tools & Services | Baron Durable Advantage Fund 2025 Q4 (DHR) We also added to our position in Danaher Corporation. Danaher supplies life... | BULL | View Pitch → |
| Jan 28, 2026 | Fund Letter | Brown Advisory LLCBrown Advisory Large-Cap Growth Strategy | Danaher Corp. $DHR• NYSE | Life Sciences Tools & ServicesLife Sciences Tools & Services | Brown Advisory Large-Cap Growth Strategy 2025 Q4 (DHR) Danaher was added as the company showed signs of renewed momentum across its businesses. Nearly 80% of... | BULL | View Pitch → |
| Jan 27, 2026 | Fund Letter | Silas Myers, Brian MasseyMar Vista US Quality | Danaher Corp. $DHR• NYSE | Life Sciences Tools & ServicesLife Sciences Tools & Services | Mar Vista US Quality 2025 Q4 (DHR) After lagging through the first three quarters of 2025, Danaher's (DHR) stock rebounded during Q4 as bioprocessing, life science, and diagnostics demand continued to recover from a cyclical trough. On the 3Q25... | BULL | View Pitch → |
| Jan 24, 2026 | Fund Letter | ArrowMark Colorado Holdings LLCMeridian Hedged Equity Fund | Danaher Corp. $DHR• NYSE | Life Sciences Tools & ServicesLife Sciences Tools & Services | Meridian Hedged Equity Fund 2025 Q4 (DHR) Danaher Corp. is a global leader in life sciences and diagnostics, with a strong presence in bioprocessing, medical research, and clinical diagnostics. We hold Danaher... | BULL | View Pitch → |
| Jan 24, 2026 | Fund Letter | Zeno Equity Partners LLPZeno | Danaher Corp. $DHR• NYSE | Life Sciences Tools & ServicesLife Sciences Tools & Services | Zeno 2025 Q4 (DHR) But what happens when a business model, built on what is second to none execution and a proven track record of capital allocation, starts to show signs of exhaustion? And what if... | BULL | View Pitch → |
| Jan 8, 2026 | Fund Letter | Maya Bittar, Dave GeislerMadison Sustainable Equity Fund | Danaher Corp. $DHR• NYSE | Life Sciences Tools & ServicesLife Sciences Tools & Services | Madison Sustainable Equity Fund 2025 Q2 (DHR) Danaher reported mixed organic growth with flat overall revenue, but its Biotechnology segment delivered 7% organic growth, marking a strong recovery from prior declines. Life Sciences and... | BULL | View Pitch → |
Join institutional and professional investors receiving our weekly analysis of hedge fund letters, market trends, and high-conviction ideas.
Zero Spam • High Alpha • Unsubscribe Anytime
Investment pitches and theses displayed on Buyside Digest are summaries of opinions expressed in publicly available investor letters, research reports, or other commentary. These summaries are generated for informational and research purposes only and do not constitute investment recommendations, financial advice, or an endorsement of any particular security or strategy by Buyside Digest. Users should conduct their own independent due diligence and consult with professional advisors before making any investment decisions.